QNCX
Quince Therapeutics, Inc.
29.20$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.71 | -0.14 | -38.84 | -40.56 | -33.64 | -34.91 | -43.70 | -48.90 | -36.80 | -37.62 | -30.45 | -3.08 | -7.65 | |
| 0.00 | 0.01 | 0.19 | 0.20 | 0.40 | 0.07 | 0.15 | 0.15 | 0.13 | 0.14 | 0.14 | 0.01 | 0.02 | |
| 7.38 | 0.03 | 5.92 | 5.68 | 5.21 | 5.20 | 6.31 | 5.45 | 4.65 | 4.27 | 5.13 | 1.97 | 2.58 | |
| -0.44 | 0.01 | -3.74 | -6.60 | -0.70 | 8.76 | 9.34 | -8.02 | 0.72 | 44.76 | -57.69 | -1.24 | -1.53 | |
| 0.00 | 0.00 | 0.18 | 0.18 | 0.21 | 0.61 | 0.67 | 0.54 | 0.27 | 0.01 | 0.02 | 0.00 | 0.01 | |
| 20.15 | – | 41.45 | -23.10 | 32.92 | 50.24 | 49.60 | 25.87 | -6.60 | – | 47.91 | 1.30 | – | |
| – | – | 296.36 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | -22.14 | 0.00 | – | |
| 0.06 | 0.00 | 0.88 | 0.16 | -23.17 | 0.00 | 0.40 | 61.74 | 5.10 | 7.30 | 37.70 | 17.76 | 19.86 | |
| -5.64 | -0.02 | 4.93 | -64.61 | -24.16 | 16.35 | 7.10 | 38.79 | -38.46 | -2.31 | 49.32 | 15.95 | 16.17 | |
| -26.71 | -0.14 | -39.02 | -40.74 | -33.85 | -35.53 | -44.37 | -49.44 | -37.08 | -37.63 | -30.45 | -3.08 | -7.66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.